Drawing for LICORBIO

USPTO serial 98477451

LICORBIO

Reviewed by CopyMark Law Group

Reg. 8179550Status 700Registered
Filing date
Status date
Registration date
Mar 17, 2026
Examiner
GEARHART, JESSICA SHEA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LICORBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole A. Katsin

Nicole A. Katsin Crown, LLP155 Montgomery Street, Suite 1401San Francisco, CA 94104United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological reagents and dyes for non-medical purposes, namely, for use in scientific research in the fields of life sciences and biotechnology for drug discovery, assessing biological processes and assays, biomolecular characteristics such as cell function, protein and gene interactions and expressions, responses, purity, and potencyACTIVENov 25, 2024
009Measuring instrumentation, downloadable software, and accessories in the fields of biotechnology and drug discovery; all for laboratory use in assessing biological processes and assays, biomolecular characteristics such as cell function, protein and gene interactions and expressions, responses, purity, and potency, not for medical purposesACTIVEMay 19, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 17, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 21, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 21, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 29, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 28, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 23, 2025IUAFUSE AMENDMENT FILED—
Jul 23, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 4, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 11, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 11, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 11, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2024DOCKASSIGNED TO EXAMINER—
Sep 3, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 1, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance